Afinitor (everolimus)
Drug timelines are a Plus or Pro feature.
7 regulatory and trial events tracked for Afinitor (everolimus), covering 2011-07-29 to 2025-04-04. Get the full timeline:
Most recent: Clinical Trial Update: Phase II Trial of Ribociclib and Everolimus in Advanced Dedifferentiated Liposarcoma (DDL) and Leiomyosarcoma (LMS) [Phase 2]